Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis
NCT ID: NCT03926637
Last Updated: 2023-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
3073 participants
OBSERVATIONAL
2019-06-17
2022-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System
NCT04599023
MSPT Device Usability Study
NCT02664324
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis
NCT00468611
Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis
NCT03632473
Study to Evaluate the Reliability and Validity of the Modified Manual Muscle Test for Persons With MS
NCT03603691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Participants
Participants with MS, including CIS will complete the MSPT at their standard of care visits.
Multiple Sclerosis Performance Test (MSPT)
Administered as specified in the treatment arm.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multiple Sclerosis Performance Test (MSPT)
Administered as specified in the treatment arm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of MS, including Clinically Isolated Syndrome
* Ability to understand the audio and visual instructions for the test modules
* Visual function, based on the investigator's clinical judgement that does not preclude an ability to interact with the Multiple Sclerosis Performance Test (MSPT).
Exclusion Criteria
* Participants younger than 18 years of age, unless their parent or legal guardian provides the required signed and dated informed consent and authorization to use confidential health information and the participant provides assent in accordance with national and local subject privacy regulations
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biogen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Director
Role: STUDY_DIRECTOR
Biogen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Berkeley, California, United States
Research Site
Los Angeles, California, United States
Research Site
Aurora, Colorado, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Atlanta, Georgia, United States
Research Site
Atlanta, Georgia, United States
Research Site
Chicago, Illinois, United States
Research Site
Boston, Massachusetts, United States
Research Site
Farmington Hills, Michigan, United States
Research Site
Owosso, Michigan, United States
Research Site
St Louis, Missouri, United States
Research Site
Teaneck, New Jersey, United States
Research Site
Buffalo, New York, United States
Research Site
Durham, North Carolina, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Portland, Oregon, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Pittsburgh, Pennsylvania, United States
Research Site
Dallas, Texas, United States
Research Site
Salt Lake City, Utah, United States
Research Site
Seattle, Washington, United States
Research Site
Spokane, Washington, United States
Research Site
Prague, , Czechia
Research Site
Strasbourg, , France
Research Site
Bari, , Italy
Research Site
Catania, , Italy
Research Site
Milan, , Italy
Research Site
Orbassano, , Italy
Research Site
Roma, , Italy
Research Site
Basel, , Switzerland
Research Site
Bern, , Switzerland
Research Site
Camberley, , United Kingdom
Research Site
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
US-MSG-18-11424
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.